Arcutis Biotherapeutics (ARQT) Depreciation & Amortization (CF): 2020-2025
Historic Depreciation & Amortization (CF) for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Mar 2025 value amounting to $153,000.
- Arcutis Biotherapeutics' Depreciation & Amortization (CF) fell 10.00% to $153,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $623,000, marking a year-over-year decrease of 21.64%. This contributed to the annual value of $640,000 for FY2024, which is 20.00% down from last year.
- Latest data reveals that Arcutis Biotherapeutics reported Depreciation & Amortization (CF) of $153,000 as of Q1 2025, which was up 5.52% from $145,000 recorded in Q4 2024.
- In the past 5 years, Arcutis Biotherapeutics' Depreciation & Amortization (CF) registered a high of $227,000 during Q4 2023, and its lowest value of $98,000 during Q1 2021.
- In the last 3 years, Arcutis Biotherapeutics' Depreciation & Amortization (CF) had a median value of $170,000 in 2024 and averaged $177,000.
- Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 420.00% in 2021, then tumbled by 36.12% in 2024.
- Over the past 5 years, Arcutis Biotherapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $182,000 in 2021, then declined by 12.09% to $160,000 in 2022, then soared by 41.87% to $227,000 in 2023, then slumped by 36.12% to $145,000 in 2024, then fell by 10.00% to $153,000 in 2025.
- Its Depreciation & Amortization (CF) was $153,000 in Q1 2025, compared to $145,000 in Q4 2024 and $161,000 in Q3 2024.